C Mariette

Summary

Affiliation: CHRU de Lille
Country: France

Publications

  1. ncbi Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez CHRU, Place de Verdun, 59037 Lille Cedex, France
    World J Surg 29:39-45. 2005
  2. ncbi [Mesenteric panniculitis]
    G Piessen
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHU, Place de Verdun 59037, Lille Cedex, France
    Ann Chir 131:85-90. 2006
  3. ncbi [Is there still a role for surgery in esophageal carcinoma in 2007?]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, Place de Verdun, CHRU, 59037 Lille Cedex
    Bull Cancer 94:63-9. 2007
  4. doi The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire, Lille, France
    Ann Surg 247:365-71. 2008
  5. pmc Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
    Antoine Adenis
    Gastrointestinal Oncology Department, Centre Oscar Lambret, 3 rue Combemale, 59020 Lille Cedex, France
    BMC Cancer 13:413. 2013
  6. ncbi [Radiotherapy and chemotherapy in the treatment of oesophageal carcinoma]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 129:489-96. 2004
  7. ncbi Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France University of Lille II, Lille, France
    Lancet Oncol 8:545-53. 2007
  8. ncbi Surgery alone in the curative treatment of localised oesophageal carcinoma
    C Mariette
    Service de chirurgie digestive et générale Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Eur J Surg Oncol 30:869-76. 2004
  9. ncbi Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Lille, France
    Ann Thorac Surg 78:1177-83. 2004
  10. ncbi [What's new in esophageal cancer treatment]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, CHRU, Lille
    Presse Med 36:496-500. 2007

Detail Information

Publications89

  1. ncbi Esophageal carcinoma: prognostic differences between squamous cell carcinoma and adenocarcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez CHRU, Place de Verdun, 59037 Lille Cedex, France
    World J Surg 29:39-45. 2005
    ..In conclusion, the clinical, histologic, and oncologic differences between SCC and ADC justify a differentiated therapeutic concept for these two tumor entities and distinct consideration in clinical reports...
  2. ncbi [Mesenteric panniculitis]
    G Piessen
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHU, Place de Verdun 59037, Lille Cedex, France
    Ann Chir 131:85-90. 2006
    ..Mesenteric panniculitis usually has an uneventful clinical course and resolves spontaneously in a variable delay...
  3. ncbi [Is there still a role for surgery in esophageal carcinoma in 2007?]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, Place de Verdun, CHRU, 59037 Lille Cedex
    Bull Cancer 94:63-9. 2007
    ....
  4. doi The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire, Lille, France
    Ann Surg 247:365-71. 2008
    ....
  5. pmc Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
    Antoine Adenis
    Gastrointestinal Oncology Department, Centre Oscar Lambret, 3 rue Combemale, 59020 Lille Cedex, France
    BMC Cancer 13:413. 2013
    ..To identify predictors of long-term outcome for patients with clinical complete response (cCR) after definite chemoradiotherapy (CRT) or radiation therapy (RT) for oesophageal cancer (EC)...
  6. ncbi [Radiotherapy and chemotherapy in the treatment of oesophageal carcinoma]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 129:489-96. 2004
    ..Surgery appears more and more as an adjuvant therapy in the curative treatment of oesophageal cancer, especially for advanced tumours...
  7. ncbi Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France University of Lille II, Lille, France
    Lancet Oncol 8:545-53. 2007
    ..Moreover, surgery should be kept in mind as salvage treatment in patients with no morphological response or persistent tumour after definitive chemoradiotherapy...
  8. ncbi Surgery alone in the curative treatment of localised oesophageal carcinoma
    C Mariette
    Service de chirurgie digestive et générale Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Eur J Surg Oncol 30:869-76. 2004
    ..To document the results of surgery alone in patients with localised oesophageal carcinoma...
  9. ncbi Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Lille, France
    Ann Thorac Surg 78:1177-83. 2004
    ..To identify factors affecting postoperative course and survival after esophagectomy for cancer and reasons for improved survival over time...
  10. ncbi [What's new in esophageal cancer treatment]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, CHRU, Lille
    Presse Med 36:496-500. 2007
    ..For patients whose tumor is inoperable, a combination of radiation and chemotherapy is the standard treatment...
  11. ncbi [Perioperative care in digestive surgery. Guidelines for the French society of digestive surgery (SFCD)]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU de Lille, Place de Verdun, 59037 Lille, France
    Ann Chir 130:108-24. 2005
  12. ncbi [Perioperative care in digestive surgery]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU, Lille
    J Chir (Paris) 142:14-28. 2005
  13. ncbi [Apprenticeship in laparoscopic surgery: Tools and methods for the surgeon in training]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHU Lille
    J Chir (Paris) 143:221-5. 2006
    ..This new technology should enable a better preparation of young surgeons for the operating room of the future...
  14. ncbi [A case of stomach cancer]
    C Mariette
    Service de Chirurgie Digestive et Générale CHRU, Lille
    J Chir (Paris) 142:184-6. 2005
  15. ncbi [Surgical management of post-operative peritonitis]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHU, Lille
    J Chir (Paris) 143:84-7. 2006
    ..Imaging exams such as CT will aid in diagnosis and guide the therapeutic approach. Treatment specifically adapted to the etiologic cause must be thorough and complete from the start...
  16. ncbi [Laparoscopic fundoplication: current data]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 142:278-83. 2005
    ..Long-term follow-up is required to evaluate dysphagia and quality-of-life...
  17. ncbi Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma
    C Mariette
    Department of Digestive and General Surgery, University Hospital Claude Huriez, Centre Hospitalier Regional Universitaire, France
    Br J Surg 93:1077-83. 2006
    ..The aim of this study was to determine the effect of neoadjuvant radiochemotherapy (RCT) on postoperative complications and survival after surgery for locally advanced oesophageal squamous cell carcinoma...
  18. ncbi Activation of MUC1 mucin expression by bile acids in human esophageal adenocarcinomatous cells and tissues is mediated by the phosphatidylinositol 3-kinase
    Christophe Mariette
    Inserm Unit 837, and Department of Digestive and Oncological Surgery, University Hospital Claude Huriez, Lille Cedex, France
    Surgery 143:58-71. 2008
    ....
  19. ncbi [Diverticula of the middle third of the oesophagus: resection via right thoracotomy]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hôpital C Huriez CHRU, Lille
    J Chir (Paris) 142:378-80. 2005
  20. ncbi The safety of the same-day discharge for selected patients after laparoscopic fundoplication: a prospective cohort study
    Christophe Mariette
    Department of Digestive and General Surgery, C Huriez Hospital University Hospital Center, Place de Verdun 59037, Lille Cedex, France
    Am J Surg 194:279-82. 2007
    ..We conducted a prospective cohort study to assess the acceptability, feasibility and safety of day-case laparoscopic fundoplication for gastroesophageal reflux disease in an university-based tertiary care center...
  21. ncbi [Complications following oesophagectomy: mechanism, detection, treatment and prevention]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU, Lille
    J Chir (Paris) 142:348-54. 2005
    ..Anastomotic leak, conduit necrosis, and pulmonary failure are the most serious complications. The management of complications following oesophagectomy is reviewed in the following section...
  22. doi Oesophagogastric junction adenocarcinoma: which therapeutic approach?
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Lille, France
    Lancet Oncol 12:296-305. 2011
    ..Through a team approach, members from all diagnostic and therapeutic disciplines, such as gastroenterologists, surgeons, oncologists, radiologists, and radiotherapists, can effectively administer a range of treatment modalities...
  23. ncbi [Practical considerations in prescribing immunonutrition]
    C Mariette
    Service de chirurgie digestive et générale Hôpital C Huriez, CHRU Lille
    J Chir (Paris) 145:9S10-4. 2008
    ..In a question-and-answer format, we discuss the practical aspects of prescribing immunonutrition to provide assistance in this area and thus optimize the application of the guidelines and patient management...
  24. ncbi [Lymphadenectomy in surgery for cancers of the stomach and esophagus]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 145:12S21-12S29. 2008
    ..Articles from the surgical literature with the highest levels of evidence are analyzed. Practical guidelines for treatment choice are proposed...
  25. ncbi [Esophagectomy by triple approach: primary thoracotomy, laparotomy, and cervicotomy - The MacKeown Procedure]
    C Mariette
    Service de chirurgie digestive et générale Hôpital C Huriez, CHRU Lille
    J Chir (Paris) 143:373-7. 2006
  26. pmc Is there a place for esogastric cancer surgery in cirrhotic patients?
    Christophe Mariette
    Department of Digestive and Oncological Surgery, University Hospital C Huriez Centre Hospitalier Régional Universitaire and University of Lille II, Place de Verdun, 59037, Lille Cedex, France
    Ann Surg Oncol 15:680-2. 2008
  27. ncbi [Patients surviving 5 years after curative oesophagectomy for oesophageal cancer]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU, Place de Verdun, 59037 Lille, France
    Ann Chir 128:536-42. 2003
    ..To analyse the clinical and pathological parameters of 5-year survival patients after curative oesophageal resection for cancer and to identify factors predictive of long-term survival...
  28. doi Diagnosis and treatment of non-metastatic esophagogastric junction adenocarcinoma: what are the current options?
    C Gronnier
    Department of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 149:e23-33. 2012
    ..A multidisciplinary approach is essential for optimal diagnosis and management...
  29. ncbi Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction
    C Mariette
    Service de chirurgie digestive et générale Hôpital Claude Huriez, CHRU de Lille Place de Verdun, 59037 cedex, Lille, France
    Eur J Surg Oncol 29:588-93. 2003
    ..We report the correlations between resection margin involvement and outcome...
  30. ncbi Surgical management of carcinoma of the hypopharynx and cervical esophagus: analysis of 209 cases
    J P Triboulet
    Service de Chirurgie Digestive et Generale, Clinique Chirurgicale Adultes Est, Chru Lille Hopital Huriez, Place de Verdun, 59037 Lille Cedex, France
    Arch Surg 136:1164-70. 2001
    ....
  31. ncbi Surgical management of and long-term survival after adenocarcinoma of the cardia
    C Mariette
    Service de Chirurgie Digestive et Generale, Hôpital Claude Huriez Centre Hospitalier Regional Universitaire, Place de Verdun, 59037 Lille Cedex, France
    Br J Surg 89:1156-63. 2002
    ..The choice of surgical strategy for patients with adenocarcinoma of the oesophagogastric junction is controversial. This study was performed to analyse the surgical results of a 20-year experience with these lesions...
  32. doi [Treatment of thoracic anastomotic leaks after oesophagectomy with self-expanding and extractible covered stent]
    A Brams
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU de Lille, Place de Verdun, 59037 Lille Cedex, France
    Gastroenterol Clin Biol 32:41-5. 2008
    ..Intrathoracic, covered oesophageal stents appears to reduce leak-morbidity after oesophagectomy and may be considered as a cost-effective treatment alternative...
  33. ncbi [Reconstruction after total circular pharyngolaryngectomy: comparison between gastric interposition and free jejunal flap]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU place de Verdun, 59037 Lille, France
    Ann Chir 127:431-8. 2002
    ..To elucidate hospital mortality, morbidity and actuarial survival rates of patients with carcinoma of the hypopharynx and cervical oesophagus and to identify the technique of choice for reconstruction after pharyngolaryngectomy...
  34. ncbi Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: who will benefit from surgery?
    Guillaume Piessen
    Department of Digestive and Oncological Surgery, University Hospital Claude Huriez Centre Hospitalier Régional Universitaire, Lille, France
    Ann Surg Oncol 14:2036-44. 2007
    ..Salvage surgery may have a survival benefit otherwise complete. Our aim was to identify predictors of R0 resection in these patients...
  35. ncbi Longitudinal analysis of quality of life (QoL) within a randomized phase III trial in patients (pts) with metastatic pancreatic adenocarcinoma (MPA)
    F Bonnetain
    FFCD INSERM U866, Dijon, France CHRU Marseille AP HM, Marseille, France Hôpital Ambroise Paré AP HP, Boulogne, France Centre de Lutte contre le Cancer Val d aurelle, Montpellier, France Hopitaux Nord de Marseille AP HM, Marseille, France Centre de Lutte Contre le Cancer Eugène Marquis, Rennes, France CHRU, Lille, France
    J Clin Oncol 27:e17544. 2009
    ..To longitudinally compare QoL according to treatment sequence we have explore definitions of time until definitive deterioration (TUDD) of QoL scores according to minimal clinically important difference (MCID) cut off...
  36. ncbi [Preoperative prognostic factors for squamous cell carcinomas of the thoracic esophagus]
    C Mariette
    , , CHRU, Lille
    Gastroenterol Clin Biol 25:468-72. 2001
    ..009). CONCLUSION: Our study confirms that dysphagia and nodal involvement on the CT-scan are simple preoperative prognostic factors in patients with resectable squamous cell carcinoma of the thoracic esophagus...
  37. ncbi Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France
    Br J Surg 90:1367-72. 2003
    ..This study evaluated the relationship between preoperative EUS findings, completeness of surgical resection and survival...
  38. ncbi Factors predictive of complete resection of operable esophageal cancer: a prospective study
    Christophe Mariette
    Service de Chirurgie Digestive et Générale Hôpital Claude Huriez and Unité INSERM 560 CHRU, Lille, France
    Ann Thorac Surg 75:1720-6. 2003
    ..The purpose of this study was to prospectively identify the factors predictive of complete resection of operable esophageal cancers...
  39. pmc Transcriptional regulation of human mucin MUC4 by bile acids in oesophageal cancer cells is promoter-dependent and involves activation of the phosphatidylinositol 3-kinase signalling pathway
    Christophe Mariette
    Unité INSERM 560, Place de Verdun, 59045 Lille Cedex, France
    Biochem J 377:701-8. 2004
    ..This new mechanism of regulation of MUC4 mucin gene points out an important role for bile acids as key molecules in targeting MUC4 overexpression in early stages of oesophageal carcinogenesis...
  40. ncbi FOLFIRI chemotherapy in patients with advanced non resectable esophageal or junctional adenocarcinoma: a pilot study
    C Ferte
    Department of Medical Oncology, University Hospital, Lille, France
    J Chemother 23:358-61. 2011
    ..To conclude, FOLFIRI regimen appears quite active, with an acceptable safety profile in patients with advanced esophageal or junctional adenocarcinoma...
  41. ncbi [Cervical and upper-third thoracic oesophageal carcinoma: a single pathological entity?]
    G Piessen
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHU Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 130:86-91. 2005
    ..Cervical and upper-third thoracic oesophageal carcinomas are considered as a single pathological entity. The aim of this study was to compare postoperative and oncological results after surgical resection in these two locations...
  42. ncbi [Oesophageal cancer in patients with head and neck cancers: therapeutic implications]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 127:757-64. 2002
    ..To determine therapeutic and prognostic implications of an associated head and neck primary cancer in patients undergoing oesophagectomy for squamous cell carcinoma of the oesophagus...
  43. ncbi Acute respiratory disease syndrome with preoperative chronomodulated chemoradiotherapy in patients with esophageal cancer. Early termination of a phase I trial
    A Adenis
    Department of Gastrointestinal and Urological Oncology, Centre Oscar Lambret, Lille, France
    Eur J Surg Oncol 34:30-5. 2008
    ..Without definitively ruling out any possible impact of chronomodulation in that setting, our data reinforce the need of a better selection of patients aimed to be treated by CRT plus surgery...
  44. ncbi Surgery after induction chemoradiotherapy for oesophageal cancer
    P Guillem
    Department of Digestive and General Surgery, University Hospital, 59037, Lille, France
    Eur J Surg Oncol 29:158-65. 2003
    ..We discuss the role of surgery after induction chemoradiotherapy, when a complete response is apparent...
  45. ncbi Peptic ulcer of the gastric tube after esophagectomy for cancer: clinical implications
    G Piessen
    Department of Digestive and General Surgery, University Hospital Claude Huriez, Lille, Cedex, France
    Dis Esophagus 20:542-5. 2007
    ..Long-term treatment with an anti-secretory proton pump inhibitor may decrease esophageal complications of duodeno-gastric-esophageal reflux and could prevent the recurrence of gastric tube ulcers...
  46. doi Effects of hybrid minimally invasive oesophagectomy on major postoperative pulmonary complications
    N Briez
    Departments of Digestive and Oncological Surgery, University Hospital C Huriez, Centre Hospitalier Regional Universitaire de Lille, France
    Br J Surg 99:1547-53. 2012
    ..The aim of this study was to test the hypothesis that hybrid minimally invasive oesophagectomy (HMIO) decreases the 30-day MPPC rate without compromising oncological outcomes...
  47. ncbi Adenocarcinoma in a gastric tube after esophagectomy for esophageal carcinoma
    A Lamblin
    Service de Chirurgie Digestive et Generale, CHRU, Lille, France
    Dis Esophagus 16:158-9. 2003
    ..We report three cases of patients who had this clinical presentation. We suggest an approach to postoperative management of ESCC to identify early tumors in gastric tubes and to allow endoscopic or surgical curative treatment...
  48. doi Outcome of day-case laparoscopic fundoplication for gastro-esophageal reflux disease
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 148:50-3. 2011
    ..To assess the acceptability, feasibility and results of day-case laparoscopic fundoplication for gastro-esophageal reflux disease (GERD) in an university tertiary care center...
  49. ncbi [Oesophageal squamous cell carcinoma stade III. State of surgery after radiochemotherapy (RCT)]
    J P Triboulet
    Service de Chirurgie Digestive et Generale, Rez de Jardin Aile Ouest, Hopital Claude Huriez, Place de Verdun, 59037 Lille Cedex, France
    Cancer Radiother 10:456-61. 2006
    ..Surgery may be proposed for selected non-responders patients and some complete pathology response in expert center...
  50. doi Oesophageal cancer: how radical should surgery be?
    C Mariette
    Department of Digestive and Oncological Surgery, Centre Hospitalier Regional Universitaire, University Hospital C Huriez, Place de Verdun, 59037 Lille Cedex, France
    Eur J Surg Oncol 38:210-3. 2012
    ..Oesophagectomy for carcinoma can be viewed as comprising two components: resection of the oesophagus and resection of the enveloping lymphatics. Controversy exists regarding how extensive these two components should be...
  51. doi Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma
    G Piessen
    INSERM, U837, Team 5 Mucins, epithelial differentiation and carcinogenesis Centre de Recherche Jean Pierre Aubert, Place de Verdun, Lille Cedex, France
    J Clin Pathol 62:1144-6. 2009
    ....
  52. doi Day-case versus inpatient laparoscopic fundoplication: outcomes, quality of life and cost-analysis
    C Gronnier
    Department of Digestive and Oncological Surgery, University Hospital Claude Huriez, Centre Hospitalier Regional Universitaire, Place de Verdun, 59037, Lille Cedex, France
    Surg Endosc 28:2159-66. 2014
    ....
  53. doi Reconstruction after gastrectomy: which technique is best?
    G Piessen
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU de Lille, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 147:e273-83. 2010
    ..In the long-term, quality of life seems better mainly in patients with small-resected tumors associated with a good prognosis...
  54. pmc Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha
    Guillaume Piessen
    Unité INSERM 560, Place de Verdun, 59045 Lille Cedex, France
    Biochem J 402:81-91. 2007
    ..These results bring new insights into MUC4 up-regulation in oesophageal carcinoma associated with bile reflux...
  55. ncbi Photodynamic therapy for early oesophageal cancer
    V Maunoury
    Gastroenterology Department, University Hospital, Lille, France
    Dig Liver Dis 37:491-5. 2005
    ..Photodynamic therapy is an endoscopic treatment of early cancers based on the photosensitisation of neoplasms following the administration of a photosensitiser prior to laser light-induced tissue destruction...
  56. doi [Oesophageal cancer: what's new during the last 10 years?]
    Jean Pierre Triboulet
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, rue Polonovski, 59037 Lille Cedex
    Bull Cancer 95:425-31. 2008
    ..Therapeutic strategies have markedly changed for 10 years, and their respective place is specified for each histological types and according to tumour location...
  57. doi Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation
    Guillaume Piessen
    Department of Digestive and Oncological Surgery, University Hospital Claude Huriez, Lille, France
    Ann Surg 250:878-87. 2009
    ..To test the hypothesis that signet ring cell (SRC) histology has a negative prognostic value in patients with gastric adenocarcinoma (ADC)...
  58. pmc Relationships between mucinous gastric carcinoma, MUC2 expression and survival
    Emmanuelle Leteurtre
    INSERM U560, Lille, France
    World J Gastroenterol 12:3324-31. 2006
    ....
  59. doi Multicentre study of neoadjuvant chemotherapy for stage I and II oesophageal cancer
    S Bekkar
    Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France
    Br J Surg 103:855-62. 2016
    ..The benefit of neoadjuvant chemotherapy (NCT) for early-stage oesophageal cancer is unknown. The aim of this study was to assess whether NCT improves the outcome of patients with stage I or II disease...
  60. doi Recent improvements in the management of esophageal anastomotic leak after surgery for cancer
    M Messager
    Univ Lille, Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, F 59000 Lille, France Univ Lille, UMR S 1172 JPARC Centre de Recherche Jean Pierre AUBERT Neurosciences et Cancer, F 59000 Lille, France INSERM, UMR S 1172, F 59000 Lille, France
    Eur J Surg Oncol . 2016
    ....
  61. ncbi [Interest in agents for adhesion prevention after gynecologic surgery]
    S Ait Menguellet
    clinique de gynécologie, Hopital Jeanne de Flandre, Centre Hospitalier Régional Universitaire CHRU de Lille, 2, Avenue Oscar Lambret, 59037 Lille Cedex, France
    Gynecol Obstet Fertil 35:290-6. 2007
    ..As far as other barrier agents are concerned, data are still insufficient to recommend them for clinical use. There is a need for other randomised controlled trials in order to evaluate functional efficiency of anti adhesion agents...
  62. ncbi [Total gastrectomy for cancer with Roux-en-Y esophago-jejunostomy reconstruction]
    N Briez
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU Lille
    J Chir (Paris) 145:147-52. 2008
  63. ncbi [Diaphragmatic hernia after esophagectomy: 2 case reports and review of the literature]
    A Franceschi
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU, 59037 Lille, France
    Ann Chir 127:62-4. 2002
    ..The aim of this study was to report two cases of transhiatal herniation following esophagectomy, to analyse the contributing factors of this complication and to expose the preventive treatment, by means of a review of the literature...
  64. ncbi [Gastric diverticulum]
    F Bouras
    Service de Chirurgie Digestive et Generale, Hôpital C Huriez CHRU, Lille, France
    J Chir (Paris) 144:145. 2007
  65. ncbi Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease
    Christophe Mariette
    Service de chirurgie digestive et générale Hôpital Claude Huriez, CHRU, Lille, France
    Cancer 97:1616-23. 2003
    ..The current study was undertaken to evaluate the pattern of recurrence after curative esophagectomy for cancer of the thoracic esophagus and to identify factors predictive of recurrent disease...
  66. ncbi [Factors predictive of complete resection of operable esophageal cancer: review of 746 patients]
    Christophe Mariette
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU, 59037 Lille Cedex, France
    Gastroenterol Clin Biol 26:454-62. 2002
    ..The purpose of this work was to identify retrospectively the factors predictive of complete resection of operable esophageal cancers...
  67. ncbi Impact of first-line and second-line PFS definitions within a randomized phase III trial in patients (pts) with metastatic pancreatic adenocarcinoma (MPA)
    L Dahan
    CHU Timone, Marseille, France FFCD, Dijon, France Hôpital Ambroise Paré, Boulogne, France Val d Aurelle, Montpellier, France Hôpital Nord, Marseille, France Centre Eugène Marquis, Rennes, France CHU Lille, Lille, France
    J Clin Oncol 27:e15583. 2009
    ..The aim of this ancillary study was to investigate definitions of 1st and 2nd line PFS and their impacts on results...
  68. ncbi Effect of neoadjuvant chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: A multicentric comparative study
    C Mariette
    Department of Surgical Oncology, University Hospital of Lille, Lille, France Department of Surgical Oncology, University of Lille, Lille, France University Hospital Saint Antoine, Paris, France University Hospital Lyon, Lyon, France Institut Gustave Roussy, Villejuif, France University Hospital of Rennes, Rennes, France University Hospital of Angers, Angers, France University Hospital of Toulouse, Toulouse, France University hospital of Strasbourg, Strasbourg, France Institut Paoli Calmettes, Marseille, France University Hospital of Rouen, Rouen, France University Hospital of Clermont Ferrand, Clermont Ferrand, France University Hospital of Tours, Tours, France Clinique Jules Vernes, Nantes, France University Hospital of Nimes, Nimes, France University Hospital of Montpellier, Montpellier, France University Hospital of Marseille, Marseille, France University Hospital Amrose Pare, Boulogne, France
    J Clin Oncol 29:4036. 2011
    ..The aim of this study was to evaluate the survival impact of neoadjuvant chemotherapy (NCT) in patients with gastric SRC through a large national comparative cohort...
  69. ncbi Outcome of the nonrandomized patients in the FFCD 9102 trial: Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus
    J Jouve
    University Hospital Bocage, Dijon, France University Hospital, Rouen, France University Hospital, Lille, France Anticancer Center, Dijon, France University Hospital, Reims, France Anticancer Center, Nancy, France University Hospital, Clermont Ferrand, France University Hospital, Angers, France University Hospital, Caen, France University Hospital, Dijon, France
    J Clin Oncol 26:4555. 2008
    ..What about nonrandomized patients (Bedenne L et al. J Clin Oncol 2007;25:1160-8)?..
  70. doi Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone
    W B Robb
    Department of Digestive and Oncological Surgery, Lille University Hospital, Lille, France
    Br J Surg 103:117-25. 2016
    ..An understanding of patterns of disease recurrence is important for subsequent treatment planning...
  71. doi Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations
    G Piessen
    Department of Digestive and Oncological Surgery, University Hospital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France University of Lille Nord de France, France Inserm UMR 837, Jean Pierre Aubert Research Center, Team 5 Mucins, epithelial differentiation and carcinogenesis, Lille, France Electronic address
    Eur J Surg Oncol 40:1746-55. 2014
    ..The differential characteristics between oesophageal and gastric SRC tumours are unknown. We aimed to investigate the role of tumour location on prognosis in OG SRC...
  72. doi Practice patterns in complex ventral hernia repair and place of biological grafts: a national survey among French digestive academic surgeons
    C Mariette
    Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Place de Verdun, 59037 Lille Cedex, France Electronic address
    J Visc Surg 151:9-16. 2014
    ....
  73. ncbi [In Process Citation]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 145:12S21-9. 2008
    ..Articles from the surgical literature with the highest levels of evidence are analyzed. Practical guidelines for treatment choice are proposed...
  74. ncbi [In Process Citation]
    C Mariette
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU Lille
    J Chir (Paris) 145:12S21-9. 2008
    ..Articles from the surgical literature with the highest levels of evidence are analyzed. Practical guidelines for treatment choice are proposed...
  75. ncbi [Type I neurofibromatosis, pheochromocytoma and somatostatinoma of the ampulla. Literature review]
    R Caiazzo
    Service de Chirurgie Digestive et Generale, Hopital C Huriez, CHRU, Place de Verdun, 59037 Lille Cedex, France
    Ann Chir 131:393-7. 2006
    ..This pathological association appears non hasardous and surgical ampullectomy offers a good alternative to pancreaticoduodenectomy in localised tumors treatment...
  76. ncbi [Urothelial tumor and colonic cancer in the context of a syndrome of hereditary predisposition to HNPCC colonic cancer]
    A de la Taille
    Service de Chirurgie Viscerale, Hopital Claude Huriez, Lille, France
    Prog Urol 10:1204-7. 2000
    ....
  77. ncbi A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis
    Nicolas Jonckheere
    Unité INSERM 560, Place de Verdun, 59045 Lille Cedex, France
    Oncogene 23:5729-38. 2004
    ....
  78. doi Is there still a need for prophylactic intra-abdominal drainage in elective major gastro-intestinal surgery?
    M Messager
    Service de Chirurgie Digestive et Generale, Centre Hospitalier Regional Universitaire de Lille, Hopital Claude Huriez, Place de Verdun, 59037 Lille Cedex, France
    J Visc Surg 152:305-13. 2015
    ..While the level of evidence is high for liver resections, new randomized controlled trials are awaited regarding gastric, pancreatic and rectal surgery. ..
  79. doi Variations among 5 European countries for curative treatment of resectable oesophageal and gastric cancer: A survey from the EURECCA Upper GI Group (EUropean REgistration of Cancer CAre)
    M Messager
    Department of Surgery, Royal Marsden NHS Foundation Trust, London, United Kingdom Department of Digestive and Oncological Surgery, C Huriez University Hospital, Lille, France
    Eur J Surg Oncol 42:116-22. 2016
    ..EURECCA initiated an international survey to share and compare patient outcome for oesophagogastric cancer. The present study assessed how a uniform dataset could be introduced for oesophagogastric cancer in Europe...
  80. doi [Lymph node involvement in œsophageal cancer: surgical approach]
    C Gronnier
    Service de Chirurgie Digestive et Generale, Hopital Claude Huriez, CHRU de Lille, Place de Verdun, 59037 Lille Cedex, France
    Cancer Radiother 18:559-64. 2014
    ..Lymph node stations invaded in œsophageal and junctional cancers, lymphadenectomy, and its impact on outcomes are discussed in this review based on the highest level of evidence published data. ..
  81. doi miR-219-1-3p is a negative regulator of the mucin MUC4 expression and is a tumor suppressor in pancreatic cancer
    F Lahdaoui
    1 INSERM, UMR837, Jean Pierre Aubert Research Center JPARC, Team 5 Mucins, epithelial differentiation and carcinogenesis, rue Polonovski, Lille Cedex, France 2 Université Lille Nord de France, Lille, France 3 Centre Hospitalier Régional et Universitaire de Lille, Lille, France
    Oncogene 34:780-8. 2015
    ..Altogether, these results identify miR-219-1-3p as a new negative regulator of MUC4 oncomucin that possesses tumor-suppressor activity in PDAC. ..
  82. ncbi Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors
    Alain Sauvanet
    Department of Digestive Surgery, Hopital Beaujon, Clichy
    J Am Coll Surg 201:253-62. 2005
    ..This retrospective study aimed to evaluate mortality and morbidity after resection for AGEJ and to determine their predictive factors...
  83. ncbi Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102
    Laurent Bedenne
    University Hospital Le Bocage, Dijon, France
    J Clin Oncol 25:1160-8. 2007
    ..Therefore, a randomized trial was carried out to compare, in responders only, chemoradiation alone with chemoradiation followed by surgery in patients with locally advanced tumors...
  84. ncbi Should resectable esophageal cancer be resected?
    Christophe Mariette
    Ann Surg Oncol 13:447-9. 2006
  85. ncbi The triggering of human peritoneal mesothelial cell apoptosis and oncosis by glucose and glycoxydation products
    Eric Boulanger
    Laboratoire de Biologie Vasculaire et Cellulaire, INTS, 6 Rue A Cabanel, 75739 Paris cedex 15, France
    Nephrol Dial Transplant 19:2208-16. 2004
    ....
  86. ncbi [Extensive ganglioneuromatosis of the esophagus: uncommon location of Von Recklinghausen's disease]
    Vincent Maunoury
    Gastroenterol Clin Biol 29:1181-2. 2005
  87. ncbi [Hepatic actinomycosis associated with gastric leiomyosarcoma. A case report]
    Thérèse Delebecq
    Gastroenterol Clin Biol 26:102-3. 2002
  88. ncbi The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy
    Lionel Apetoh
    Institut Gustave Roussy IGR, Villejuif, France
    Immunol Rev 220:47-59. 2007
    ..This knowledge may be clinically exploited to predict the immunogenicity and hence the efficacy of chemotherapeutic regimens...
  89. ncbi [Primary adenocarcinoma of the cervical esophagus arising from heterotopic gastric mucosa]
    Jean Michel Balon
    Gastroenterol Clin Biol 27:836-8. 2003